In a first, US-based scientists claim to have developed a vaccine for chikungunya fever from an insect-specific virus that does not affect people. Scientists used an Eilat virus clone to design a hybrid virus-based vaccine, which is structurally identical to the natural chikungunya virus. The hybrid virus can replicate in mosquitoes, but not in mammals.